Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH

NCT01651780 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
803
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

The Medicines Company